In addition, FGF21 levels were increased at 3, 5, and 10 days of HFD‐MetR (Figure 2i), indicating a rapid hepatic response; FGF21 analogs are being considered as therapeutic treatments for fatty liver and metabolic disease (Tan et al., 2023). Here, FGF21 is linked to Hepatic steatosis.